All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Ioni
Stock
Ionis Pharmaceuticals
Pipeline
Ionis
Website
Pharmaceutical
Sales
Ionis Pharmaceuticals
Reviews
Ionis Pharmaceuticals
History
Builder Update URL Names
Ionis Pharmaceuticals
News
Ionis
Turkey
Ions Inc
Ionis Pharmaceuticals
Earnings
Ionis Pharmaceuticals
Careers
Ionis
Drug
Charity Walks 2024
Ionis Pharmaceuticals
Stock
Ionis
How It Works
Ionis Pharmaceuticals
Partners
Ion Stocks
Ionis Pharmaceutical
Lawsuits
Finnster Server Name
Ionis Pharmaceuticals
Products
ION Trading
Biontech
Gilead Sciences
Kidney Institute of Cape Coral
1 1
Ionis Complaints
Novartis
Virtual Surfing
Moderna
Dina Katabi
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Ioni
Stock
Ionis Pharmaceuticals
Pipeline
Ionis
Website
Pharmaceutical
Sales
Ionis Pharmaceuticals
Reviews
Ionis Pharmaceuticals
History
Builder Update URL Names
Ionis Pharmaceuticals
News
Ionis
Turkey
Ions Inc
Ionis Pharmaceuticals
Earnings
Ionis Pharmaceuticals
Careers
Ionis
Drug
Charity Walks 2024
Ionis Pharmaceuticals
Stock
Ionis
How It Works
Ionis Pharmaceuticals
Partners
Ion Stocks
Ionis Pharmaceutical
Lawsuits
Finnster Server Name
Ionis Pharmaceuticals
Products
ION Trading
Biontech
Gilead Sciences
Kidney Institute of Cape Coral
1 1
Ionis Complaints
Novartis
Virtual Surfing
Moderna
Dina Katabi
Pfizer
Biogen
Mylan
AstraZeneca
Amgen
Ions Stock
Pharmaceutical
Sales Jobs
Pharmaceutical
Care
Ioni
Lashes
Virtual Surf
Inc.'s Ion
Hi-Tech
Pharmaceuticals
investors.com
Biotech Rockets To Four-Year High After Hitting A 'Home Run'
Ionis Pharmaceuticals scored a "home run" Tuesday after its experimental treatment for high triglycerides beat the placebo.
8 months ago
Ionis Pharmaceuticals Drugs
Ionis Pharmaceuticals annonce des résultats positifs pour l'olezarsen dans deux études de phase 3 sur l'hypertriglycéridémie sévère
zonebourse.com
6 months ago
Ionis Pharmaceuticals présente de nouvelles données issues de l'étude pivot sur le zilganersen dans la maladie d'Alexander
zonebourse.com
1 month ago
Why This Top 5% Biotech Shot To A Six-Year High
investors.com
7 months ago
Top videos
Transcript : Ionis Pharmaceuticals, Inc. Presents at Stifel 2026 Virtual CNS Forum, Mar-17-2026 11
zonebourse.com
2 months ago
Ionis 2025 Corporate Responsibility Report: RNA Medicine, ESG & Sustainability | IONIS
ionis.com
4 weeks ago
Ionis Pharmaceuticals, Inc. Announces Positive Results from Phase 2 Study of ION224
marketscreener.com
Mar 13, 2024
Ionis Pharmaceuticals Stock
Ionis Pharmaceuticals : 2023 Ionis Investor Day Presentation
marketscreener.com
Oct 4, 2023
Oppenheimer Maintains an “Outperform Rating” on Pharmaceuticals, Inc. (IONS)
Yahoo
Fatima Gulzar
1 week ago
US FDA approves Ionis Pharma's genetic disorder drug
marketscreener.com
Dec 19, 2024
Transcript : Ionis Pharmaceuticals, Inc. Presents at Stifel 2026 Virtual CNS Forum, Mar-17-2026 11
2 months ago
zonebourse.com
Ionis 2025 Corporate Responsibility Report: RNA Medicine, ESG & Sustainability | IONIS
4 weeks ago
ionis.com
Ionis Pharmaceuticals, Inc. Announces Positive Results from Phase 2 Study of ION224
Mar 13, 2024
marketscreener.com
Ionis CEO on olezarsen, Dawnzera, and more at H.C. Wainwright summit | BiotechTV posted on the topic | LinkedIn
8 months ago
linkedin.com
Ionis Pharmaceuticals, Inc. | LinkedIn
Jul 6, 2023
linkedin.com
US FDA approves Ionis Pharma's genetic disorder drug
Dec 19, 2024
marketscreener.com
Ionis Pharmaceuticals founder Stanley Crooke on the fight against rare diseases
10 months ago
MSN
CNBC
Ionis announces positive results from fesomersen development program
Nov 7, 2022
marketscreener.com
2:47
Dr. Stanley Crooke, the founder of Ionis Pharmaceuticals and n-Lorem, joined "Squawk Box" to discuss the fight against rare diseases, the development of ASOs and more. Watch more of the interview here: cnb.cx/46lsTzB | CNBC
1.3K views
10 months ago
Facebook
CNBC
6:32
Ionis Pharmaceuticals CEO Brett Monia on the drugs they are focused on
7 months ago
MSN
CNBC
9:53
Ionis Surges Into Buy Zone After It, Possibly, Proved Biogen Wrong
Jul 22, 2024
investors.com
9:07
Ionis Pharmaceuticals founder Stanley Crooke on the fight against rare diseases
10 months ago
CNBC
$
A ‘Groundbreaking’ New Drug Shows Promise Against Huntington’s—But There’s a Catch
Dec 11, 2017
Fortune
Sy Mukherjee
Ionis Pharmaceuticals, Inc.: WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy
7 months ago
finanznachrichten.de
0:33
At Ionis, our work is more than just science, it’s about people. Behind every treatment we pursue is a commitment to delivering hope, care and impact. Learn more about how we're changing the course of human health through our dedicated efforts: https://ionis.com/ | Ionis Pharmaceuticals
344 views
9 months ago
Facebook
Ionis Pharmaceuticals
0:12
Ionis is proud to announce that we have ranked #6 on the San Diego Business Journal’s 2025 Best Places to Work list. This marks our second consecutive year being recognized and our first year breaking into the Top 10. Our ranking reflects the dedication of every Ion—in Carlsbad and beyond—who contributes to the exceptional workplace culture that fuels our mission to improve the lives of patients around the world. Read more: https://ionis.com/newsroom/people-impact/best-place-to-work-2025 #BestPl
123 views
7 months ago
Facebook
Ionis Pharmaceuticals
0:31
This past week, Ionis joined leaders in neurology at the 54th Child Neurology Society Annual Meeting to share knowledge and advance science for children living with neurological conditions. Meetings like #CNS2025 help amplify the stories, voices and science driving change in neurology. #CNSAM | Ionis Pharmaceuticals
293 views
7 months ago
Facebook
Ionis Pharmaceuticals
$
Isis Pharmaceuticals Changes Its Name After Terrorists Attack Stock Price
Dec 18, 2015
Fortune
Jen Wieczner
0:34
ISIS Pharmaceuticals changes its name
Dec 18, 2015
CNBC
Morgan Brennan
1:00
TRYNGOLZA CTV (60 seconds)
5 views
4 months ago
Vimeo
Ionis Pharmaceuticals
22:47
Ionis Pharmaceuticals $3 billion commercial pivot
2 views
2 weeks ago
YouTube
Q10 AI INSIGHTS
Ionis Rings the Nasdaq Stock Market Opening Bell
Mar 24, 2025
nasdaq.com
4:00
Drug Company Hearing - SNL
8.2M views
Mar 5, 2017
YouTube
Saturday Night Live
57:48
Antisense Oligonucleotides for Prion Disease
4.2K views
Oct 7, 2020
YouTube
CJD Foundation
4:10
Ionic bonds | AP Chemistry | Khan Academy
147.8K views
Oct 30, 2019
YouTube
Khan Academy
4:30
The science of snowflakes - Maruša Bradač
640.4K views
Dec 22, 2015
YouTube
TED-Ed
1:16:45
Antisense Oligonucleotides- Mechanisms of Action and Rational Design
20.3K views
Feb 27, 2020
YouTube
Oligonucleotide Therapeutics Society
19:57
为什么摄影师都喜欢用长焦镜头?
30.3K views
7 months ago
YouTube
摄影讲师伍伍
3:21
Why Ionis
1.1K views
Sep 27, 2021
YouTube
Ionis Pharmaceuticals
See more
More like this
Feedback